Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2011 Jun 7;91(9):813–822. doi: 10.1002/bdra.20836

Table 1.

Number of birth defects surveillance programs evaluated in this review and their main characteristics

Birth Defects surveillance networks Number of surveillance programs Microtia-Anotia reporting Ascertainment Years considered Pregnancy outcome ascertained
EUROCAT 26 Anotia only registered Population-based Longest available period up to 2007 LB, SB, ETOPFA (b)
ICBDSR 39 Microtia and Anotia are differentiated (a) Mostly population-based Longest available period up to 2007 LB, SB, ETOPFA (c)
NBDPN 27 Microtia and Anotia are not differentiated Population-based 2002–2006 LB, SB, ETOPFA (d)

LB = Livebirth, SB = Stillbirth, ETOPFA = Elective termination of pregnancy for fetal anomalies

(a)

Anotia and microtia are not differentiated in China CBDMN, Finland, Japan JAOG, and Mexico RYVEMCE

(b)

ETOPFA are not reported in Poland and Poland Wielkopolska

(c)

ETOPFA are not reported in Canada British Columbia, Canada National, China Beijing, China CBDMN, Italy Sicily, Japan JAOG, Spain ECEMC, and Ukraine

(d)

ETOPFA are not reported in Alaska, Arizona, Colorado, Florida, Illinois, Indiana, Kentucky, Massachusetts, Michigan, Mississippi, Nebraska, New Jersey, New York, Rhode Island, Tennessee, Virginia, and Wisconsin